Similar articles

• Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.

  Patel A. Patel A. Eur Urol. 2008 May;53(5):982-3. doi: 10.1016/j.eururo.2007.10.051. Epub 2007 Nov 5. Eur Urol. 2008. PMID: 17997023 No abstract available.
• Reassessing the diagnostic yield of saturation biopsy of the prostate.

  Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Ashley RA, et al. Eur Urol. 2008 May;53(5):976-81. doi: 10.1016/j.eururo.2007.10.049. Epub 2007 Nov 5. Eur Urol. 2008. PMID: 17997028
• Editorial comment on: Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy.

  Badalyan R. Badalyan R. Eur Urol. 2008 Mar;53(3):545-6. doi: 10.1016/j.eururo.2007.06.042. Epub 2007 Dec 27. Eur Urol. 2008. PMID: 17619080 No abstract available.
• Medical technologies for the diagnosis of prostate cancer.

  Fitzsimons NJ, Sun L, Moul JW. Fitzsimons NJ, et al. Expert Rev Med Devices. 2007 Mar;4(2):227-39. doi: 10.1586/17434440.4.2.227. Expert Rev Med Devices. 2007. PMID: 17359227 Review.
• [Two major diagnostic innovations in the management of prostate cancer].

  Doublet JD, Cornu JN, Rouprêt M. Doublet JD, et al. Prog Urol. 2007 Apr;17(2 Suppl 1):285-6. Prog Urol. 2007. PMID: 17569271 Review. French. No abstract available.